Pembrolizumab trials for NSCLC (Non-small Cell Lung Cancer)

All Pembrolizumab trials · All NSCLC (Non-small Cell Lung Cancer) trials

Phase breakdown

Recruiting trials studying Pembrolizumab for NSCLC (Non-small Cell Lung Cancer)

• A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
  NCT06835569 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Study of XB010 in Subjects With Solid Tumors
  NCT06545331 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
  NCT04585750 · Phase: Phase 1, Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · 154 locations

Common questions

How many trials study Pembrolizumab for NSCLC (Non-small Cell Lung Cancer)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.